Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph

来源 :中国癌症研究(英文版) | 被引量 : 0次 | 上传用户:showfeeling
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To develop and validate a radiomics-based predictive risk score (RPRS) for preoperative prediction of lymph node (LN) metastasis in patients with resectable non-small cell lung cancer (NSCLC).Methods:We retrospectively analyzed 717 who underwent surgical resection for primary NSCLC with systematic mediastinal lymphadenectomy from October 2007 to July 2016.By using the method of radiomics analysis,591 computed tomography (CT)-based radiomics features were extracted,and the radiomics-based classifier was constructed.Then,using multivariable logistic regression analysis,a weighted score RPRS was derived to identify LN metastasis.Apparent prediction performance of RPRS was assessed with its calibration,discrimination,and clinical usefulness.Results:The radiomics-based classifier was constructed,which consisted of 13 selected radiomics features.Multivariate models demonstrated that radiomics-based classifier,age group,tumor diameter,tumor location,and CT-based LN status were independent predictors.When we assigned the corresponding score to each variable,parents with RPRSs of 0-3,4-5,6,7-8,and 9 had distinctly very low (0%-20%),low (21%-40%),intermediate (41%-60%),high (61%-80%),and very high (81%-100%) risks of LN involvement,respectively.The developed RPRS showed good discrimination and satisfactory calibration [C-index:0.785,95% confidence interval (95% CI):0.780-0.790].Additionally,RPRS outperformed the clinicopathologic-based characteristics model with net reclassification index (NRI) of0.711 (95% CI:0.555-0.867).Conclusions:The novel clinical scoring system developed as RPRS can serve as an easy-to-use tool to facilitate the preoperatively individualized prediction of LN metastasis in patients with resectable NSCLC.This stratification of patients according to dheir LN status may provide a basis for individualized treatment.
其他文献
1.Overviewrn2.Screening and diagnosisrn2.1 Surveillance and screening of high-risk populationrn2.2 Diagnosis of melanomarn2.2.1 Clinical symptomsrn2.2.2 Imaging
期刊
As the first monoclonal antibody against vascular endothelial growth factor (VEGF),bevacizumab (BEV) is a definitely controversial antiangiogenic therapy in bre
磁性纳米材料在目前的医学领域中应用广泛,在肿瘤热疗、药物载体、核磁影像中都有所应用.本文就磁流体修饰及其在肿瘤治疗中的应用做一综述.
Objective:China have implemented population-based esophageal cancer (EC) screening programs,however,the participant rates were relatively low.This study was con
原发性肝细胞癌(简称肝癌)目前尚无有效的治疗手段,五年生存率很低.由于癌肿本身代谢异常或癌组织对机体发生各种影响引起的内分泌或代谢方面的症候群称副癌综合征,在临床诊
Objective:Growing evidence indicates that FAT atypical cadherin 1 (FAT1) has aberrant genetic alterations and exhibits potential tumor suppressive function in e
Objective:To investigate the clinical significance of MET gene amplification in patients with gastric cancer in the palliative setting.Methods:MET amplification
Aim: To investigate the androgen receptor (AR) isoform expressions in human prostatic cancer tissue and LNCaP cell line. Methods: With high resolution isoelectr
随着肿瘤综合治疗方案的广泛应用,胸部肿瘤治疗的疗效有了显著的提高,但是放射性肺损伤( radiation-induced lung injury)的出现,使得其成为限制胸部肿瘤放射治疗靶区剂量提